Table 1.
General patient information and CEUS features of the lesions.
| Group | Num. | Gender | Age/Years | Location | Maximum Diameter/cm | |||||
| Male | Female | Left Lobe | Right Lobe | <3 | ≥3 | |||||
| HCC | 61 | 50 (82.0) | 11 (18.0%) | 55.540 ± 10.096 | 15 (24.6%) | 46 (75.4%) | 23 (37.7%) | 38 (62.3%) | ||
| OM | 38 | 24 (63.2%) | 14 (36.8%) | 58.530 ± 11.215 | 11 (28.9%) | 27 (71.1%) | 3 (7.9%) | 35 (92.1%) | ||
| X2/t | - | 4.389 | −1.338 | 0.230 | 10.744 | |||||
| p | - | 0.036 | 0.185 | 0.632 | 0.001 | |||||
| Group | Num. | Enhancement Pattern in AP | Degree of Wash-Out | Time to Wash Out/s | ||||||
| Non-Rim APHE |
Rim
APHE |
Non APHE | Mild | Marked | Non | <60 | ≥60 | Non-Wash Out | ||
| HCC | 61 | 58 (95.1%) | 2 (3.3%) | 1 (1.6%) | 54 (88.5%) | 3 (4.9%) | 4 (6.6%) | 11 (18.0%) | 46 (75.4%) | 4 (6.3%) |
| OM | 38 | 14 (36.8%) | 22 (57.9%) | 2 (5.3%) | 13 (34.2%) | 25 (65.8%) | 0 (0%) | 32 (84.2%) | 6 (15.8%) | 0 (0%) |
| X2/t | - | 40.745 | 43.373 | 41.946 | ||||||
| p | - | <0.001 | <0.001 | <0.001 | ||||||
HCC = hepatocellular carcinoma, OM = other primary malignancies, APHE = arterial phase hyperenhancement, AP = arterial phase. - = No comparison of the number of cases between the two groups.